Cochlear has received FDA approval for the Nucleus 7 (N7, or CP1000) BTE processor.  This doesn’t mean the processor is available today – it’s up to the company to determine when it will be available.

Preliminary features and differences between the N7 and N6 include:

• Supports Hybrid (EAS) hearing
• Made for iPhone compatibility
• The telecoil is optimized for loops
• Compatible with the Nucleus Smart App (iOS devices remote control app)
• Remote control (volume, sensitivity, & program settings, telecoil, audio accessory)
• Remote assistant replaced by iOS app – compatible Apple device required. Includes tracking function to help locate a lost processor.
• One processor size option.  The N6 has two options, the larger of which allows for Direct Connect inputs.

The Nucleus 7 is not compatible with Nucleus 22 or Nucleus 24 implants.

Stay tuned for more information as it becomes available!